Lettland - Lettisch - Zāļu valsts aģentūra

alvogen ipco s.a.r.l, luxembourg - bortezomibs - pulveris injekciju šķīduma pagatavošanai - 3,5 mg

Europäische Union - Lettisch - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - denges - vakcīnas - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 un 4. izmantot dengvaxia būtu saskaņā ar oficiālās rekomendācijas.

Europäische Union - Lettisch - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - limfoma, mantle-cell - antineoplastiski līdzekļi - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

Lettland - Lettisch - Adama

adama - emulsijas koncentrāts/suspensijas koncentrāts - azoksistrobīns + protiokonazols - fungicīdi

Europäische Union - Lettisch - EMA (European Medicines Agency)

takeda gmbh - dengue virus, serotype 2, expressing dengue virus, serotype 1, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 3, surface proteins, live, attenuated, dengue virus, serotype 2, expressing dengue virus, serotype 4, surface proteins, live, attenuated, dengue virus, serotype 2, live, attenuated - denges - vakcīnas - qdenga is indicated for the prevention of dengue disease in individuals from 4 years of age. the use of qdenga should be in accordance with official recommendations.

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

powerbar europe gmbh - cits, Želeja

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

powerbar europe gmbh - cits, Želeja

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

kapsula

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

powerbar europe gmbh - cits, želeja

Lettland - Lettisch - Pārtikas un veterinārais dienests, Zemkopības ministrija

farma balt sia - cits, droga